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Introduction
There is dispute about the impact that  elevated estradiol (E2) 
levels (or a high number of retrieved oocytes) at the time of 
human chorionic gonadotropin (hCG) administration may 
have on pregnancy for a subgroup of higher responder patients 
having in vitro fertilization (IVF) treatments. Studies showing 
either no adverse effects or appalling pregnancy rates (PRs) 
of high serum E2 levels have been published [1-5]. It has 
been suggested  that  increased ovarian steroid hormone 
secretion from controlled ovarian hyperstimulation (COH) 
The impact of pregnancy rates  of using two different cut-off levels 
for high serum estradiol levels on the day of the hCG injection:  
Results from the same cohort of patients with long down-regulated 
ART cycles
Aynı YÜT hasta kohortunda hCG günü oluşturulan iki farklı serum östradiol eşik değerlerinin 
YÜT gebelikleri üzerine etkileri
Tevfik YOLDEMİR
Tevfik Yoldemir ()
Department of Obstetrics and Gynecology, School of Medicine, Marmara 
University, Istanbul, Turkey
e-mail: dr_yoldemir@hotmail.com
Submitted/Başvuru: 25.06.2013          Accepted/Kabul: 02.08.2013
ÖZET
Amaç: Yardımcı üreme teknikleri (YÜT) uygulanan hasta 
kohortunda insan koriyonik gonadotropin (hCG) günü 
oluşturulan iki farklı serum östradiol (E2) eşik değerlerinin 
YÜT gebelikleri üzerine etkilerinin araştırılması. 
Hastalar ve Yöntem: Üniversiteye bağlı eğitim hastanesinde 
uzun süreli gonadotropin salgılayıcı hormon baskısından sonra 
kullanılan rekombinant folikül stimüle edici hormon (FSH) ile 
YÜT tedavisi alan 539 ardışık kadın retrospektif analize alınmıştır. 
hCG günü alınan serum E2 seviyesinin yüksek eşik değeri persentil 
analizine göre yapılmıştır. Grup 1 için serum E2 seviyeleri 25–
75inci persentilde (1040-2500pg/ml)olanlar alt grup A ; serum 
E2 seviyeleri 75–100üncü persentilde (>2500pg/ml)olanlar alt 
grup B olarak ayrılmıştır. Grup 2 için serum E2 seviyeleri 10–
90ıncı persentilde olanlar(650-3100pg/ml) alt grup A ve serum 
E2 seviyeleri 90–100üncü persentilde (>3100pg/ml)olanlar alt 
grup B olarak ayrılmıştır. Klinik ve devam eden gebelik oranları 
karşılaştırılmıştır. 
Bulgular: Hem grup 1’de hem de grup 2’de klinik ve gebelik 
oranları benzerdir. 
Sonuç: hCG günü serum E2 seviyelerinin eşik değeri 75inci 
(2500pg/ml), veya 90ıncı persentil (3100pg/ml) üzerinde olması 
GnRH analogları ile baskılanmış uzun protokol YÜT sikluslarında 
gebelik oranlarını olumsuz etkilememektedir.
Anahtar kelimeler: Gonadotropin salgılayıcı hormon analogu, 
İnsan korionik gonadotropin, Gebelik, Uzun analog siklusu, 
Östradiol
ABSTRACT 
Objective: To determine,  from a single cohort of patients 
whether  on the day of the  human chorionic gonadotropin 
(hCG)  injection,   two different cut-off levels for high serum 
estradiol (E2)  levels  affect pregnancy rates in long-down 
regulated  assisted reproductive technology (ART)  cycles. 
Patients and Methods: A retrospective cohort analysis was 
performed in a University affiliated  hospital on 539 women 
undergoing consecutive in vitro fertilization/intacytoplasmic sperm 
injection (IVF/ICSI) treatment with long-down regulation and 
recombinant follicular stimulating hormone (FSH) injections. The 
cut-off  level for high E2 concentration was calculated according to 
a centile analysis of  E2 levels on the day of hCG administration. 
Women  in  group 1 were divided into subgroup A with E2 levels from 
the 25th to 75th centiles (1040-2500pg/ml) and subgroup B with E2 
levels from the 75th  to 100th centiles (>2500pg/ml), respectively. 
Women in group 2 were divided into subgroup A with E2 levels 
from the 10th to 90th centile (650-3100pg/ml) and subgroup B with 
E2 levels from the 90th to 100th centile (>3100pg/ml), respectively. 
The clinical pregnancy rates  and ongoing pregnancy rates were 
compared. 
Results: The clinical pregnancy rates and ongoing pregnancy 
rates were similar  in   group 1 and group 2. 
Conclusion: High serum E2 levels on the day of  the hCG 
injection day either set at 75th (2500pg/ml) or 90th percentiles 
(3100pg/ml) do not compromise pregnancy rates in cycles down-
regulated with gonadotropin-releasing hormone (GnRH) analogues.
Key words: Gonadotropin-releasing analogue, Human chorionic 
gonadotropin, Pregnancy, long analogue  cycle, Estradiol
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may   compromise endometrial receptivity for embryo 
implantation [6,7]. However, conflicting reports exist 
concerning the impact of COH on pregnancy rates after 
IVF-embryo transfers  (ET) [8–10]. Simon et al [3] and 
Yu Ng et al [11] reported reduced pregnancy rates, while 
Chenette [12] and Gelety and Buyalos [13]  found that 
higher clinical pregnancies  were  obtained from IVF cycles 
with high E2 levels. High responders have been defined 
variously as patients who had peak E2 level of > 3000 pg/
ml(conversion factor of 3.671), > 15 retrieved oocytes or > 
10 retrieved oocytes [11].
Although implantation results from good quality embryos, 
this is not the only factor contributing to successful implantation, 
because the maternal endometrium is at least of equal relevance. 
In IVF, the main reason for the low implantation results is 
that the quality of the endometrial factor is affected during 
pharmacological treatments (hormonal therapy (HT) and 
COH), and this can be proven when comparing implantation 
and pregnancy rates in normal cycles versus IVF and oocyte 
donation recipients [14]. As the aim of ovulation induction 
is to recruit more oocytes, and subsequently more good 
quality embryos, supraphysiological concentrations of steroid 
hormones (oestradiol and progesterone) are produced that 
may affect endometrial receptivity [15]. Altered regulation of 
steroid receptor expression in the human endometrium could 
be implicated since a significant reduction in nuclear receptors 
for progesterone and E2 in both the glands and stroma, has 
been demonstrated in COH cycles [16].
Arbitrary threshold E2 levels on the day of hCG 
administration have been used to create groups of patients 
for comparison, but also percentile analysis of E2 levels 
have been   used. Studies suggesting that there is a positive 
or a negative association between E2 levels and the chance 
of pregnancy failed to concur  on a threshold level of E2 at 
which the probability of pregnancy is significantly altered. 
We aimed to determine whether two different cut-off values 
for high serum   E2 levels on the day of the hCG injection 
in the same cohort of patients affect pregnancy rates in long-
down regulated ART cycles.  
Patients and Methods
Five hundred and thirty-nine consecutive women undergoing 
IVF/ICSI cycles at the ART unit in a university affliated 
hospital, formed  the cohort of patients from which two study 
groups  were  constructed. In none of these patients had  the 
cycles were  been cancelled. In study group 1 the women 
were placed into two subgroups according to a centile 
analysis of E2 levels on the day of  the hCG administration, 
the subgroups being  from the 25th to 75th percentile and 
from 75th  to  100th percentile, where 2500 pg/ml was the 
cut-off point.  Study group 2 consisted of women divided into 
two subgroups on the basis of E2 levels on the day of hCG 
administration from the 10th to 90th percentile and  from the 
90th  to  100th percentile, where 3100 pg/ml was the cut-off 
point.  The data from patients in the lower 25th  percentile in 
group 1 and lower 10th  percentile in group 2 were excluded. 
All practices and protocols conformed to the ethical 
requirements for ART   programs of the Ethics Commitee 
of the institution and  conformed  with  the provisions of the 
Declaration of Helsinki. 
All patients underwent ovarian stimulation with 
gonadotropins and gonadotropin releasing hormone (GnRH)-
agonist for pituitary down-regulation. For long protocols, 
pituitary desensitisation was achieved by s.c. administration 
of leuprolide acetate during the luteal phase of the preceding 
cycle before the start of gonadotropin stimulation. COH was 
accomplished with s.c. administration of recombinant FSH 
(Follitropin alpha; Serono). The initial standard gonadotropin 
dose was 225 IU recFSH for normo-responders. If age was 
over 35, starting gonadotropin dose 300IU was considered. 
Ten thousand IU of human chorionic gonadotropin (hCG, 
10,000 IU Profasi, Serono) was administered when at least one 
follicle had a mean diameter of 18 mm. Transvaginal oocyte 
retrieval was performed 35 or 36 h after hCG injection. The 
scoring system used for the selection of  embryos to transfer 
at cleavage stage was previously described [17]. Implantation, 
clinical  pregnancy rates and ongoing pregnancy rates  were 
compared between the groups.
Statistical Evaluation
All analyses used StataSE 10.0 software (Statacorp, 
Texas, USA). Statistical analysis was by Student’s t-test on 
mean values and by the  chi-square test on outcome rates 
related to pregnancy outcomes ; p<0.05 was considered 
significant. 
Results
There were 264 women in subgroup A and 147 in subgroup B 
of group 1.    128  patients who had E2 levels below the 25th 
percentile on the day of hCG administration were excluded. 
The mean age, serum level of FSH on cycle day 3 and the 
body mass index (BMI) were similar between groups. 
Indications for ART in subgroup A were male factor (36.9%), 
tubal (19.2%), minimal endometriosis (9.4%), polycystic 
ovary syndrome (PCOS)  (6.3%) or unexplained infertility 
(31%).  The corresponding   percentages in sugroup B were 
34.5%, 28.2%, 8.5%, 7% and 24.6%, respectively. The 
duration of gonadotropin stimulation and the total dose 
of FSH used were alike in subgroups A and B.  The mean 
number of eggs collected and the mean  number of mature 
and fertilized oocytes were higher in subgroup B. On day 3, 
the mean number of embryos with more than 6 cells were 
higher  in subgroup B than in subgroup A.  However,  the 
average scores of transfered embryos were comparable in 
subgroups A and B (Table I). 
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Table I. The patient demographics and cycle characteristics of the study groups
Group 1 Group 2
Subgroup A 
(n=264)
Subgroup B 
(n=147) P value
Subgroup A 
(n=411)
Subgroup B 
(n=56) P value
Age (years) 33.94± 4.30 33.70 ± 4.63 0.60 33.99± 4.32 34.07 ± 4.77 0.90
Body mass index (kg/m2) 26.15± 7.43 25.81± 6.34 0.68 26.34 ± 7.39 25.33 ± 6.34 0.36
Cycle day 3 FSH (mIU/ml) 6.09± 2.14 5.75 ± 1.98 0.12 6.22 ± 2.29 5.60 ± 2.03 0.06
Duration of  stimulation with gonadotropin 
(days) 9.49± 1.45 9.52 ± 1.32 0.84 9.49± 1.56 9.45 ± 1.23 0.86
Duration of GnRH analogue (days) 29.03± 6.54 27.63± 3.95 0.02 28.82 ± 5.94 26.97 ± 3.72 0.02
Total dose of FSH used (IU) 2792.33± 1022.35 2611.74± 972.54 0.08 2828.37± 1108.05 2545± 950.58 0.06
E2 level on the day before hCG day  (pg/ml) 1213.62± 381.50 2038.65± 525.43 0.0001 1243.67± 525.40 2254.38± 637.32 0.0001
E2 level on hCG day  (pg/ml) 1697.23± 432.43 3090.63± 490.25 0.0001 1762.31± 699.99 3572.87± 439.97 0.0001
E2 level per oocyte  retrieved (pg/ml) 163.48± 97.65 181.76 ±  67.83 0.054 165.68± 89.53 182.18 ± 75.02 0.21
Number of aspirated oocytes per retrieval 12.45± 5.47 19.11± 7.83 0.0001 12.35± 6.08 22.07± 9.45 0.0001
Number of inseminated oocytes per retrieval 11.33± 5.24 17.46± 8.14 0.0001 11.14 ± 5.70 21.21± 9.62 0.0001
Number of  fertilized oocytes per retrieval 7.98± 4.73 12.02± 7.22 0.0001 7.79± 4.98 14.82± 8.23 0.0001
Number of embryos transferred on day 3 3.30± 0.86 3.29± 0.85 0.91 3.32± 0.84 3.43± 0.91 0.44
Average WIH score of embryos transfered on 
day 3 * 6.61± 1.17 6.58± 1.33 0.81 6.55± 1.21 6.73± 1.24 0.36
All values are given as mean and standard deviation (SD)
P< 0.05 is statistically significant
* The sum of “development+ fragmentation+symmetry”of each embryo transferred divided by number
Table II. Pregnancy outcomes 
Group 1 Group 2
Subgroup A 
(n=264)
Subgroup B 
(n=147) P value
Subgroup A 
(n=411)
Subgroup B 
(n=56) P value
Implantation rate per transfer 22.34± 0.31 21.42±0.28 0.79 20.74± 0.29 23.29± 0.30 0.60
Average WIH score* of transferred embryos 
that resulted in clinical pregnancy 7.02 ± 0.99 6.88 ± 1.17 0.39 6.92 ± 1.06 7.02 ± 1.00 0.68
Clinical pregnancy per day 3 transfer 125
(49.80%)
79
(58.09%)
0.12 210
(51.85%)
32
(59.26%)
0.31
Average WIH score* of transferred embryos 
that resulted in ongoing pregnancy 7.08 ± 1.00 6.95 ± 1.08 0.49 6.98 ± 1.07 6.98 ± 0.77 0.99
Ongoing pregnancy per day 3 transfer 107
(43.27%)
67
(49.63%)
0.23 176
(43.86%)
25
(47.17%)
0.65
WIH scores are given as mean and standard deviation (SD)
Pregnancy outcomes are given as number, and percentage (%) in parentheses
P< 0.05 is statistically significant
* The sum of “development+ fragmentation+symmetry”of each embryo transfered divided by number
There were 411 women in subgroup A and 56 in subgroup 
B of group 2. Seventy two patients who had E2 levels below 
the 10th percentile on the day of hCG administration were 
excluded.  The mean age , serum level of FSH on cycle day 
3 and BMI were similar between groups. Indications for 
ART in subgroup A were male factor (36.2%), tubal (21.3%), 
minimal endometriosis (9%), PCOS (6.4%) or unexplained 
infertility (29.8%).  The corresponding percentages of 
distribution in subgroup B were 31.6%, 33.3%, 12.3%, 
5.3% and 19.3%, respectively. The duration of gonadotropin 
stimulation and the total dose of FSH used were alike in 
subgroups A and B. Just as the mean serum E2 levels  on 
the day of  hCG  administration were higher in  subgroup 
B so were the mean number of eggs collected and the mean 
number of mature and fertilized oocytes were higher. On 
day 3, the mean number of embryos with more than 6 cells 
were more in subgroup B than in subgroup A.  However,  the 
average score of transfered embryos were comparable in 
subgroups A and B (Table I). 
The mean clinical pregnancy rates per cleavage stage 
transfer were  alike between the subgroups of groups  1 and 
2. Similarly, the  ongoing pregnancy rates  per cleavage stage 
transfer were almost the same for  the subgroups of  groups 
A and B  (Table II). 
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Discussion 
In most reports where groups of patients were used for 
comparisons, the groups  were created by arbitrary threshold E2 
levels on the day of  hCG administration. Interval increments 
of one thousand or five hundred, and also percentile analysis 
of E2 levels have been  used [18]. We have compared the 
fresh  ET  results in long down - regulated ART cycles. We 
grouped our cohort of infertile women according to a centile 
analysis of E2 levels on the day of hCG administration. Two 
cut-off points were chosen for high E2 levels: 75 percentile 
and 90 percentile. In the literature differences in the type of 
analogue or in the analogue protocol used and in the day 
on which the embryo transfer took place, have affected the 
observed results so that they vary from one another. We have 
included ART cycles where only recombinant FSH was used 
for COH after long down-regulation with GnRH analogue 
used for COH. Criteria used for  triggering the final oocyte 
maturation were  based solely on follicular diameters. The 
hCG was administered as soon as a threshold of follicular 
development was reached, regardless of E2 levels [19,20].
Supraphysiological levels of E2 during IVF-ET cycles 
have been incriminated as having a detrimental effect on 
endometrial receptivity and pregnancy [3-11-14-21,22]. On 
the contrary,  increased pregnancy rates have been proposed 
by other studies [12, 13].  Chenette et al. [12] grouped 216 
patients in three groups according to E2 levels on the day 
of hCG   administration (<1722, 1722–2777, >2777 pg/ml) 
and noted that significantly higher clinical pregnancy rates 
per oocyte retrieval were  observed in the highest E2 group 
compared with the other groups. Gelety and Buyalos [13] 
compared 25 patients undergoing IVF  who had E2 levels 
on the day of hCG >5000 pg/ml with 25 patients in whom 
E2 levels were <3500 pg/ml (control group). The control 
group was matched for age, duration and type of infertility, 
and stimulation protocol. A higher clinical pregnancy rate per 
embryo transfer was observed in the high E2 group. More 
embryos were transferred in the high compared with the low 
E2 group, although the difference was marginally significant.
Embryo quality and endometrial receptivity have been 
identified as important determinants of reproductive outcome 
in assisted reproduction [14-23]. In our study embryos 
were transferred at the  cleavage stage. Average embryo 
scores were comparable between the subgroups. Decreased 
implantation rates have been claimed when the developing 
endometrium was exposed to the effects of COH [8-21,22]. 
In contrast to previous reports, [9-21,22] we observed similar 
clinical and ongoing pregnancy rates between the subgroups 
in both study groups.
Simon et al. [3] divided patients into  eight groups 
according to E2 levels on the day of hCG administration 
using 500 pg/ml increments (from 500 to >3500 pg/ml). 
A significantly lower pregnancy rate per cycle started was 
observed in the groups of patients with higher E2 levels 
(E2 >2500 pg/ml) compared with those with lower E2 
levels (E2 <2500 pg/ml). Ng et al. [11] divided patients 
into three groups according to E2 levels on the day of hCG 
administration (<10.000, 10.000–20.000, >20.000 pmol/l). 
A significantly lower clinical pregnancy rate per embryo 
transfer was observed in the group of patients with E2 levels 
>20.000 pmol/l compared with those with E2 levels between 
10.000 and 20.000 pmol/l. Similar numbers of embryos were 
transferred in the groups compared.
Toner et al.[4] found that despite a slight decrease in 
fertilization rates in those cycles with > 10 retrieved oocytes, 
pregnancy rates were not different between the groups. In 
our study subgroups with E2 concentrations more than the 
cut-off level, there were more fertilized oocytes than the 
subgroups with lower E2 levels.  Just as Tarin et al [24] 
showed no difference in pregnancy rates between low-to-
moderate and high responders so  we observed  no difference 
in  either the clinical  or the ongoing pregnancy rates 
between the subgroups . We observed that with high estradiol 
levels more surplus embryos are likely to be available for 
cryopreservation and used for later cryo-ETs. The presence 
of embryos suitable for freezing suggested that the embryo 
quality was not affected in a negative way.
Contrary to studies showing either negative or positive 
associations of pregnancy with high levels of E2 on the 
day of  hCG  administration there are reports confirming 
that high E2 levels did   do not appear to adversely affect 
embryo quality and consequent pregnancy rates [5]. Sharara 
and McClamrock [25] analysed 106 patients in four groups 
according to E2 levels on the day of hCG administration, 
using thousand interval increments (<2000, 2000–3000, 
3000–4000, >4000 pg/ml).  Papageorgiou et al. [26] divided 
762 patients into three groups according to  a centile analysis 
of E2 levels on the day of hCG administration (0–10th centile, 
10th –90th centile, 90th – 100th centile).  Chen et al. [27] 
used centile analysis to divide 697 patients in three groups 
according to E2 levels on day of hCG administration (<1289, 
1289–2495, >2495 pg/ml). In agreement with these studies 
we have found that clinical pregnancy rates  per embryo 
transfer were similar between our study subgroups no matter 
which cut-off level was chosen for the high E2 level.
We have investigated for the first time where two cut-
off levels for high E2 level were formed in the same cohort 
of patients and pregnancy outcomes were analysed. Cut-off 
levels set either at the 75th  percentile or 90th  percentile will 
not compromise pregnancy rates. Hence,  each ART program 
must consider their distribution of E2 on the day of hCG 
administration  and establish their line of action accordingly. 
Since high E2 levels on the day of  hCG administration  did 
not seem to adversely affect pregnancy rates, serum E2 
surveillance should be offered only in some subset of cycles 
where the risk of ovarian hyperstimulation syndrome is high. 
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